Skip to main content
Top
Published in: BMC Gastroenterology 1/2021

Open Access 01-12-2021 | Acute Abdomen | Case report

Fibromuscular dysplasia of mesenteric arteries: a rare cause of multiple bowel resections—a case report and literature review

Authors: Shuwen Du, Shanbing Yang, Kangmei Jia, Peng Du, Limin Zhang, Jiheng Wang, MD

Published in: BMC Gastroenterology | Issue 1/2021

Login to get access

Abstract

Background

Fibromuscular dysplasia (FMD) is a type of unexplained nonatherosclerotic vascular disease that usually involves the renal and internal carotid arteries and rarely involves the mesenteric artery. Mesenteric artery FMD is difficult to distinguish from Crohn’s disease (CD) and Behcet’s disease (BD) solely based on symptoms. Patients with mesenteric artery FMD can present with an acute abdomen, but case reports of patients who have a long medical history and undergo multiple bowel resections are extremely rare.

Case presentation

The patient was a 45-year-old woman with an 11-year history of intermittent lower abdominal pain and fever. At the age of 34 years, she underwent right hemicolectomy and appendectomy due to an acute abdomen. She suffered from oral ulcers between 34 and 36 years old. A clinical diagnosis of presumed CD was made by the age of 41, and she was treated with mesalazine; however, the effect was poor. At the age of 42, she came to our centre, and based on her atypical symptoms and examination results, we thought she had CD. Hence, she was treated with glucocorticoids for 3 years. However, when she was 45, due to steroid dependence, thalidomide tablets were added. Unfortunately, she suffered from another episode of intestinal obstruction. Therefore, she underwent enterectomy. The postoperative histopathological diagnosis was mesenteric artery FMD. She no longer underwent pharmacotherapy after the surgery. Although she did not have any of her previous symptoms and postoperative colonoscopy showed no signs of recurrence, splenomegaly and abnormal routine blood results were still present.

Conclusions

Patients with mesenteric artery FMD can present with an acute abdomen. In addition, the symptoms and endoscopic manifestations of mesenteric artery FMD may appear similar to CD and BD. Hence, it is difficult to make a clear clinical diagnosis and proceed with treatment. Mesenteric artery FMD often requires surgical pathology to confirm its diagnosis. For patients who suffer from this disorder, surgery may be the best choice to improve the patient’s quality of life.
Appendix
Available only for authorised users
Literature
1.
go back to reference Patil DT, Kissiedu J, Rodriguez ER, Downs-Kelly E, Liu X, Rybicki LA, Tan CD. Mesenteric arteriovenous dysplasia/vasculopathy is distinct from fibromuscular dysplasia. Am J Surg Pathol. 2016;40(10):1316–25.CrossRef Patil DT, Kissiedu J, Rodriguez ER, Downs-Kelly E, Liu X, Rybicki LA, Tan CD. Mesenteric arteriovenous dysplasia/vasculopathy is distinct from fibromuscular dysplasia. Am J Surg Pathol. 2016;40(10):1316–25.CrossRef
2.
go back to reference Jinnouchi H, Finn AV, Virmani R. Nonatherosclerotic vascular disease in women. Tex Heart Inst J. 2018;45(4):233–5.CrossRef Jinnouchi H, Finn AV, Virmani R. Nonatherosclerotic vascular disease in women. Tex Heart Inst J. 2018;45(4):233–5.CrossRef
3.
go back to reference Lüscher TF, Lie JT, Stanson AW, Houser OW, Hollier LH, Sheps SG. Arterial fibromuscular dysplasia. Mayo Clin Proc. 1987;62(10):931–52.CrossRef Lüscher TF, Lie JT, Stanson AW, Houser OW, Hollier LH, Sheps SG. Arterial fibromuscular dysplasia. Mayo Clin Proc. 1987;62(10):931–52.CrossRef
4.
go back to reference Hamed RM, Ghandour K. Abdominal angina and intestinal gangrene–a catastrophic presentation of arterial fibromuscular dysplasia: case report and review of the literature. J Pediatr Surg. 1997;32(9):1379–80.CrossRef Hamed RM, Ghandour K. Abdominal angina and intestinal gangrene–a catastrophic presentation of arterial fibromuscular dysplasia: case report and review of the literature. J Pediatr Surg. 1997;32(9):1379–80.CrossRef
5.
go back to reference Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, Gray WA, Gupta R, Hamburg NM, Katzen BT, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–78.CrossRef Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, Gray WA, Gupta R, Hamburg NM, Katzen BT, et al. Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association. Circulation. 2014;129(9):1048–78.CrossRef
6.
go back to reference Harrison EG Jr, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971;46(3):161–7.PubMed Harrison EG Jr, McCormack LJ. Pathologic classification of renal arterial disease in renovascular hypertension. Mayo Clin Proc. 1971;46(3):161–7.PubMed
7.
go back to reference Chaturvedi R, Vaideeswar P, Joshi A, Pandit S. Unusual mesenteric fibromuscular dysplasia a rare cause for chronic intestinal ischaemia. J Clin Pathol. 2008;61(2):237.CrossRef Chaturvedi R, Vaideeswar P, Joshi A, Pandit S. Unusual mesenteric fibromuscular dysplasia a rare cause for chronic intestinal ischaemia. J Clin Pathol. 2008;61(2):237.CrossRef
8.
go back to reference Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Kim ES, Mace P, Matsumoto AH, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90.CrossRef Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Kim ES, Mace P, Matsumoto AH, et al. The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125(25):3182–90.CrossRef
Metadata
Title
Fibromuscular dysplasia of mesenteric arteries: a rare cause of multiple bowel resections—a case report and literature review
Authors
Shuwen Du
Shanbing Yang
Kangmei Jia
Peng Du
Limin Zhang
Jiheng Wang, MD
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2021
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-021-01702-y

Other articles of this Issue 1/2021

BMC Gastroenterology 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine